Abstract
India being on the 'threshold of biotech revolution' has 280 biotech and 180
bio suppliers contributing to the total biotech market worth US $100 billion.
The country has a global market worth $91 billion and there is scope for cheap
R&D through bio-partnering and co-developing technologies mainly with Chinese
and American companies. Already the world pharma companies are seeking India
to set their research and development centers here. Moreover, to facilitate
foreign investment, capital and government policies are being revised.
It has been found that Indian biotech firms are making a strong position,
developing business models and improving product commercialization
capabilities. With this, India could make a good $5 billion by 2010.
A new market research report, "Indian Biotech Industry (2005)" by RNCOS
provides insights into the Indian biotech industry including product
estimates, market segmentation, and regulatory mechanisms, pricing policies,
patents and opportunities in international venture ship. The report says how
in 2004-05, 20 privately helped drug discovery groups have started to operate
in India with their business primarily to create innovations and IPR. The
biotech industry is likely to draw huge FDI to the Union Government.
The market research report also details the success of the biotech firms in
terms of their business profiles, export outlets, financial performances and
future plans. It also has the contact details of the major industry
associations.
REPORT HIGHLIGHTS
- Assessment of what is happening in China across the value chain, the
organizational structure and, the interaction between Indo-China biotech
businesses and research.
- Changes in patent policies and Intellectual Property Rights - A strategic
analysis.
- Sales and demand analysis for biotech products in agri-business and
clinical studies, 2005-2010.
- An estimate of the recent and future investment programs in Indian
biotechnology sector and growth statistics.
- SWOT analysis of Indian biotechnology sector.
- New drafts and policies formulated by National Biotechnology Development
Authorities and how it facilitates in private-public partnerships across
biotech firms.
- Key profiles and marketing strategies.
REPORT FEATURES
The market research report "Indian Biotech Industry (2005)" prepared by RNCOS
gives a detail analysis of the Indian biotech market scenario, the
technological developments and researches. These have been divided into a
number of relevant chapters. Chapter 1 giving an introduction is followed by
chapter 2 which talks about the changing legal framework of the biotech sector
in India mentioning, fiscal incentives, changes in patents acts, plant
varieties and Farmers' Rights Protection Act, 2001 and other regulations for
the biotech sector. Chapter 3 gives the state driven initiatives and policies,
region wise.
Chapter 4 analyzes the Indian biotechnology market for 2005 in terms of size,
demand, industry segments, exports, number of companies & associations,
employment opportunities, investments and status of biotech parks. Chapter 5
gives the SWOT analysis; chapter 6 - the industry and outsourcing
opportunities; chapter 7 - R&D strengths; chapter 8 - India's New Draft
National Biotechnology Development strategy; chapter 9 - the key industry
trends and opportunities; chapter 10 - strategies for the industry's future;
chapter 11 about financial strategy for emerging bio-companies and; chapter 12
gives the company profiles of key players.
View Cart
